Erratum
for Biganzoli et al. 7 (Supplement 6): 29.
The Oncologist, Vol. 8, No. 1, 124-a124,
February 2003
© 2003 AlphaMed Press
Moving Forward with Capecitabine: A Glimpse of the Future
Laura Biganzoli,
Miguel Martin,
Chris Twelves
The Oncologist 2002;7(suppl 6):29-35
On page 31, Table 2, the legend should read "Summary of efficacy: single-agent capecitabine versus CMF as first-line treatment for metastatic breast cancer," whereas previously it read "Summary of efficacy: single-agent capecitabine versus CMF in patients with anthracycline-pretreated metastatic breast cancer." Additionally, the column headers were erroneously identified as "Capecitabine (n = 22)" and "Paclitaxel (n = 19)," respectively. The correct column headers are "Capecitabine (n = 61)" and "CMF (n = 32)," respectively.